Brain metastases, patterns of intracranial progression, and the clinical value of upfront cranial radiotherapy in patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors

BACKGROUND: Despite the emergence of programmed death 1/programmed death-ligand 1 (PD-1/PD-L1) inhibitors in the treatment of non-small cell lung cancer (NSCLC) patients with brain metastases (BMs), knowledge gaps remain regarding the impact and timing of cranial radiotherapy for patients receiving...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Tiantian, Chu, Li, Chu, Xiao, Yang, Xi, Li, Yida, Zhou, Yue, Xu, Dayu, Zhang, Jinmeng, Wang, Shengping, Hu, Jie, Chu, Qian, Moran, Teresa, Cho, William Chi-Shing, Merrell, Kenneth W., Rizzo, Stefania, Liu, Yanfei, Ni, Jianjiao, Zhu, Zhengfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902084/
https://www.ncbi.nlm.nih.gov/pubmed/35280308
http://dx.doi.org/10.21037/tlcr-22-54

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902084/
https://www.ncbi.nlm.nih.gov/pubmed/35280308
http://dx.doi.org/10.21037/tlcr-22-54

Ejemplares similares